All Pain, No GAIN:
APUA Clinical Newsletter Vol. 30 No. 1 (2012)
Once every five years, Congress re-authorizes funding for the FDA under PDUFA. In the current PDUFA legislation, Congress also addressed issues relating to antimicrobial resistance in the Generating Antibiotic Incentives Now (GAIN) Act. This short article critiques the absence of antimicrobial stewardship incentives in the GAIN Act, which is a serious error in the long-term struggle with pathogenic microbes.
Adobe Acrobat Reader v3.01 or greater is required to view this paper.
Kevin Outterson Contact Information
This draft can be also found at the link below: